Solid Power, Inc.
Business
Solid Power, Inc. is a developer and manufacturer of solid-state battery technology centered on sulfide-based solid electrolyte materials for next-generation batteries. It produces sulfide electrolytes, pilot-scale solid-state cells in multiple form factors, cell manufacturing designs, and offers licensing, engineering services, and electrolyte supply to battery producers and OEMs. The business is organized around electrolyte development and production, pilot cell development and manufacturing, partnerships with Tier 1 battery manufacturers and automakers, and licensing of cell processes. It targets the electric vehicle market globally and distributes through direct supply agreements, collaborations, sampling programs, and licensing arrangements.
Summary from filing dated 2025-02-28
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 18 | 20 | — | — | — | |
| Grant income | 4 | — | — | — | — | |
| Total revenue and grant income | 22 | 20 | 17 | 12 | 3 | |
| Direct costs | 21 | 20 | 28 | 10 | 3 | |
| Research and development | 73 | 73 | 55 | 39 | 17 | |
| Selling, general and administrative | 29 | 32 | — | — | — | |
| Total operating expenses | 123 | 125 | 108 | 71 | 29 | |
| Operating Loss | −101 | −105 | −91 | −59 | −27 | |
| Interest income | 13 | 18 | 20 | 8 | 56,000 | |
| Change in fair value of warrant liabilities | −5 | −5 | 5 | 41 | 51 | |
| Interest expense | −25,000 | −46,000 | −84,000 | — | — | |
| Other expense | −684,000 | −3 | — | — | — | |
| Total nonoperating income and expense | 7 | 10 | 25 | 49 | 45 | |
| Income (loss) before income tax expense (benefit) | −93 | −95 | −66 | — | — | |
| Income tax expense (benefit) | −8,000 | 1 | 2,000 | −227,000 | −25,000 | |
| Share of net loss (income) of equity method investee | −65,000 | 133,000 | — | — | — | |
| Net Loss Attributable to Common Stockholders | −93 | −97 | −66 | −10 | 13 | |
| Other Comprehensive Income | 315,000 | 598,000 | 3 | −3 | — | |
| Comprehensive Loss Attributable to Common Stockholders | −93 | −96 | −63 | −13 | 13 | |
| Basic loss per share | −0.51 | −0.54 | −0.37 | −0.05 | 0.13 | |
| Diluted loss per share | −0.51 | −0.54 | −0.37 | −0.05 | 0.11 | |
| Weighted average shares outstanding - Basic | 185 | 179 | 178 | 174 | 95 | |
| Weighted average shares outstanding - Diluted | 185 | 179 | 178 | 174 | 115 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 22 | 25 | 35 | 50 | 513 | |
| Marketable securities | 229 | 93 | 142 | 273 | 76 | |
| Accounts receivable | 2 | 1 | — | — | — | |
| Contract assets | 7 | 1 | 2 | 2 | 829,000 | |
| Prepaid expenses and other current assets | 7 | 6 | 6 | 3 | 4 | |
| Total current assets | 267 | 125 | 183 | 328 | 594 | |
| Property, plant and equipment, net | 86 | 97 | 99 | 83 | 22 | |
| Right-of-use operating lease assets, net | 7 | 7 | 7 | 8 | 8 | |
| Investments | 87 | 210 | 240 | 173 | — | |
| Intangible assets, net | 2 | 2 | 2 | 1 | 619,000 | |
| Other assets | 1 | 2 | 1 | 1 | 602,000 | |
| Loan receivable from equity method investee | 4 | 4 | — | — | — | |
| Total long-term assets | 188 | 323 | 350 | — | — | |
| Total assets | 455 | 448 | 533 | 594 | 618 | |
| Accounts payable and other accrued liabilities | 9 | 8 | 6 | 11 | 2 | |
| Deferred revenue | 198,000 | 3 | 1,000 | 50,000 | 500,000 | |
| Deferred revenue from related parties | 172,000 | — | 828,000 | 4 | — | |
| Accrued compensation | 7 | 8 | 8 | 5 | 1 | |
| Operating lease liabilities | 861,000 | 833,000 | 626,000 | 549,000 | — | |
| Total current liabilities | 17 | 20 | 16 | 21 | 8 | |
| Warrant liabilities | 14 | 9 | 4 | 9 | 50 | |
| Operating lease liabilities | 7 | 8 | 8 | 9 | 8 | |
| Other liabilities | 1 | 1 | 803,000 | — | 393,000 | |
| Total long-term liabilities | 22 | 18 | 14 | — | — | |
| Total liabilities | 39 | 38 | 29 | 39 | 59 | |
| Mezzanine Equity | 470,000 | 34,000 | — | — | — | |
| Common stock, $0.0001 par value; 2,000,000,000 shares authorized; 201,181,175 and 180,364,028 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 20,000 | 18,000 | 18,000 | 18,000 | 17,000 | |
| Additional paid-in capital | 690 | 591 | 589 | 578 | 568 | |
| Accumulated deficit | −275 | −181 | −85 | −19 | −10 | |
| Accumulated other comprehensive income (loss) (AOCI) | 354,000 | 39,000 | −559,000 | −3 | — | |
| Total stockholders' equity | 416 | 410 | 503 | 555 | 559 | |
| Total liabilities, mezzanine equity and stockholders' equity | 455 | 448 | 533 | 594 | 618 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 18 | 16 | 12 | 5 | 2 | |
| Amortization of right-of-use assets | 1 | 900,000 | 768,000 | 745,000 | — | |
| Loss on sales of property, plant, and equipment | 574,000 | 2 | — | — | — | |
| Gain on sales of property, plant, and equipment | −20,000 | — | — | — | — | |
| Loss on extinguishment of note receivable | — | 760,000 | — | — | — | |
| Stock-based compensation expense | 9 | 12 | 10 | 9 | 3 | |
| Accretion of discounts on other long-term liabilities | 65,000 | 78,000 | 174,000 | — | — | |
| Accretion of loan receivable from equity method investee | −131,000 | −24,000 | — | — | — | |
| Amortization of premiums and accretion of discounts on available-for-sale securities | −5 | −8 | −11 | −3 | — | |
| Loss on change in assessment of finance lease purchase options | 84,000 | — | — | — | — | |
| Impairment loss on abandoned patents | 748,000 | — | — | — | — | |
| Accounts receivable | 278,000 | 160,000 | — | — | — | |
| Contract assets | −7 | 160,000 | −31,000 | −692,000 | −552,000 | |
| Prepaid expenses and other current assets and other assets | −366,000 | 710,000 | −2 | 3 | −4 | |
| Accounts payable and other accrued liabilities | 1 | 1 | 2 | −1 | 778,000 | |
| Deferred revenue | −3 | 3 | −50,000 | −450,000 | 462,000 | |
| Deferred revenue from related parties | 172,000 | −828,000 | −3 | 4 | — | |
| Accrued compensation | −537,000 | −11,000 | 3 | 2 | — | |
| Operating lease liabilities | −996,000 | −771,000 | −549,000 | −401,000 | — | |
| Net cash and cash equivalents used in operating activities | −73 | −64 | −58 | −34 | −25 | |
| Purchases of property, plant and equipment | −10 | −16 | −35 | −58 | −13 | |
| Purchases of available-for-sale securities | −278 | −216 | −328 | −562 | −76 | |
| Proceeds from sales of available-for-sale securities | 269 | 303 | 405 | 190 | — | |
| Proceeds from sales of property, plant and equipment | 20,000 | 77,000 | — | — | — | |
| Cash paid for loan receivable from equity method investee | — | −6 | — | — | — | |
| Cash paid for equity method investment | — | −656,000 | — | — | — | |
| Purchases of intangible assets | −873,000 | −438,000 | −556,000 | −498,000 | −381,000 | |
| Net cash and cash equivalents provided by (used in) investing activities | −20 | 64 | 43 | −430 | −89 | |
| Proceeds from exercise of stock options | 5 | 273,000 | 220,000 | 818,000 | 106,000 | |
| Proceeds from issuance of shares of common stock under the ESPP | 365,000 | 412,000 | 434,000 | — | — | |
| Cash paid for withholding of employee taxes related to stock-based compensation | −1 | −615,000 | −112,000 | −58,000 | — | |
| Repurchase of shares of common stock | −4 | −9 | — | — | — | |
| Proceeds from the ATM, net of commissions | 89 | — | — | — | — | |
| Offering costs for the issuance of common stock under the ATM | −624,000 | — | — | — | −5 | |
| Payments on finance lease liabilities | −284,000 | −427,000 | −362,000 | −142,000 | — | |
| Net cash and cash equivalents provided by (used in) financing activities | 89 | −9 | 173,000 | 485,000 | 623 | |
| Net decrease in cash and cash equivalents | −4 | −9 | −16 | −463 | 508 | |
| Cash paid for interest | 26,000 | 46,000 | 84,000 | 42,000 | 144,000 | |
| Accrued capital expenditures | 103,000 | 1 | 814,000 | 8 | — | |
| Unpaid reimbursement on capital expenditures | 1 | — | — | — | — | |
| Accrued offering costs for the issuance of common stock under the ATM | 5,000 | — | — | — | — | |
| Accrued excise tax on stock repurchases | — | 90,000 | — | — | — |